Controlled Trial of Azathioprine in Crohn's Disease

Overview

Journal Lancet

Publisher Elsevier

Specialty General Medicine

Date 1971 Dec 11

PMID 4143532

Citations 36

Authors

J Rhodes

D Bainton

P Beck

H Campbell

Affiliations

Soon will be listed here.

Abstract

The effect of azathioprine in patients with active Crohn's disease has been evaluated in a double-blind cross-over trial. Fifteen patients were treated with both azathioprine and placebo: only two improved while on azathioprine, six got worse, and in seven there was no change. The drug seemed to be the cause of deterioration in two of the patients. Although the drug may be of some value in a few patients, it should be used with caution and only when other measures have failed.

Citing Articles

Pancreatitis associated with azathioprine and 6-mercaptopurine use in Crohn's disease: a systematic review.

Gordon M, Grafton-Clarke C, Akobeng A, Macdonald J, Chande N, Hanauer S Frontline Gastroenterol. 2022; 12(5):423-436.

PMID: 35401955 PMC: 8989005. DOI: 10.1136/flgastro-2020-101405.

Thiopurines in Inflammatory Bowel Disease. How to Optimize Thiopurines in the Biologic Era?.

Gargallo-Puyuelo C, Laredo V, Gomollon F Front Med (Lausanne). 2021; 8:681907.

PMID: 34336887 PMC: 8322650. DOI: 10.3389/fmed.2021.681907.

Thiopurine monotherapy is effective in ulcerative colitis but significantly less so in Crohn's disease: long-term outcomes for 11 928 patients in the UK inflammatory bowel disease bioresource.

Stournaras E, Qian W, Pappas A, Hong Y, Shawky R, Raine T Gut. 2020; 70(4):677-686.

PMID: 33004550 PMC: 7948184. DOI: 10.1136/gutjnl-2019-320185.

Immunosuppressive therapies adversely affect blood biochemical parameters in patients with inflammatory bowel disease: a meta-analysis.

Wang X, Wang G, Shang J, Pan H, Zhang X, Zhou F J Int Med Res. 2019; 47(8):3534-3549.

PMID: 31364448 PMC: 6726787. DOI: 10.1177/0300060519864800.

Perianal Fistulas in Patients With Crohn's Disease, Part 1: Current Medical Management.

Gold S, Cohen-Mekelburg S, Schneider Y, Steinlauf A Gastroenterol Hepatol (N Y). 2018; 14(8):470-481.

PMID: 30302062 PMC: 6170888.